Table 1 Clinical and pathological data in 47 cases of patients with prostate cancer
From: Expression and clinical significance of Caveolin-1 in prostate Cancer after transurethral surgery
Item | Cases (percentage) | |
|---|---|---|
Age | < 70 | 19 (40.4%) |
≥70 | 28 (59.6%) | |
Preoperative PSA | 0–10 | 6 (12.8%) |
level (ng/ml) | 10–100 | 22 (46.8%) |
> 100 | 19 (40.4%) | |
Clinical stage | T1-T2 | 26 (55.3%) |
T3-T4 | 21 (44.7%) | |
Gleason score | 2–6 | 11 (20%) |
7 | 16(37.4%) | |
8–10 | 20(42.6%) |